News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
763,576 Results
Type
Article (53032)
Company Profile (298)
Press Release (710245)
Multimedia
Podcasts (113)
Webinars (18)
Section
Business (218526)
Career Advice (2650)
Deals (36979)
Drug Delivery (115)
Drug Development (85180)
Employer Resources (182)
FDA (17312)
Job Trends (15952)
News (368446)
Policy (35479)
Tag
Academia (2871)
Academic (1)
Accelerated approval (10)
Adcomms (26)
Allergies (103)
Alliances (54173)
ALS (118)
Alzheimer's disease (1530)
Antibody-drug conjugate (ADC) (162)
Approvals (17286)
Artificial intelligence (357)
Autoimmune disease (35)
Automation (19)
Bankruptcy (368)
Best Places to Work (12212)
BIOSECURE Act (21)
Biosimilars (131)
Biotechnology (208)
Bladder cancer (97)
Brain cancer (36)
Breast cancer (383)
Cancer (3019)
Cardiovascular disease (229)
Career advice (2230)
Career pathing (33)
CAR-T (198)
CDC (36)
Cell therapy (545)
Cervical cancer (23)
Clinical research (69779)
Collaboration (1090)
Company closure (3)
Compensation (705)
Complete response letters (29)
COVID-19 (2814)
CRISPR (64)
C-suite (352)
Cystic fibrosis (119)
Data (3091)
Decentralized trials (2)
Denatured (39)
Depression (69)
Diabetes (361)
Diagnostics (6775)
Digital health (24)
Diversity (9)
Diversity, equity & inclusion (47)
Drug discovery (157)
Drug pricing (139)
Drug shortages (31)
Duchenne muscular dystrophy (134)
Earnings (91939)
Editorial (47)
Employer branding (23)
Employer resources (159)
Events (122573)
Executive appointments (889)
FDA (19032)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (10)
Funding (990)
Gene editing (144)
Generative AI (33)
Gene therapy (416)
GLP-1 (861)
Government (4934)
Grass and pollen (6)
Guidances (183)
Healthcare (20161)
HIV (43)
Huntington's disease (30)
IgA nephropathy (43)
Immunology and inflammation (166)
Immuno-oncology (11)
Indications (40)
Infectious disease (2999)
Inflammatory bowel disease (158)
Inflation Reduction Act (12)
Influenza (65)
Intellectual property (122)
Interviews (456)
IPO (17017)
IRA (50)
Job creations (4147)
Job search strategy (1875)
Kidney cancer (14)
Labor market (53)
Layoffs (537)
Leadership (26)
Legal (8785)
Liver cancer (82)
Longevity (12)
Lung cancer (420)
Lymphoma (215)
Machine learning (11)
Management (62)
Manufacturing (421)
MASH (97)
Medical device (14291)
Medtech (14297)
Mergers & acquisitions (20696)
Metabolic disorders (908)
Multiple sclerosis (103)
NASH (19)
Neurodegenerative disease (132)
Neuropsychiatric disorders (35)
Neuroscience (2255)
NextGen: Class of 2025 (7111)
Non-profit (4932)
Now hiring (48)
Obesity (460)
Opinion (261)
Ovarian cancer (102)
Pain (116)
Pancreatic cancer (127)
Parkinson's disease (193)
Partnered (23)
Patents (315)
Patient recruitment (173)
Peanut (54)
People (61645)
Pharmaceutical (72)
Pharmacy benefit managers (24)
Phase I (21715)
Phase II (30577)
Phase III (22913)
Pipeline (1680)
Policy (229)
Postmarket research (2861)
Preclinical (9495)
Press Release (69)
Prostate cancer (149)
Psychedelics (44)
Radiopharmaceuticals (266)
Rare diseases (501)
Real estate (6433)
Recruiting (70)
Regulatory (24406)
Reports (51)
Research institute (2560)
Resumes & cover letters (428)
Rett syndrome (10)
RNA editing (9)
RSV (54)
Schizophrenia (91)
Series A (168)
Series B (116)
Service/supplier (13)
Sickle cell disease (64)
Special edition (20)
Spinal muscular atrophy (154)
Sponsored (34)
Startups (3881)
State (2)
Stomach cancer (16)
Supply chain (81)
Tariffs (62)
The Weekly (72)
Vaccines (857)
Venture capital (56)
Weight loss (293)
Women's health (49)
Worklife (19)
Date
Today (69)
Last 7 days (363)
Last 30 days (1904)
Last 365 days (32453)
2025 (17719)
2024 (36629)
2023 (41559)
2022 (52855)
2021 (57645)
2020 (56412)
2019 (49680)
2018 (37589)
2017 (34566)
2016 (34613)
2015 (40686)
2014 (34808)
2013 (30359)
2012 (32264)
2011 (32652)
2010 (31046)
Location
Africa (932)
Alabama (66)
Alaska (7)
Arizona (251)
Arkansas (13)
Asia (42948)
Australia (7112)
California (7626)
Canada (2405)
China (704)
Colorado (334)
Connecticut (342)
Delaware (194)
Europe (95834)
Florida (1139)
Georgia (260)
Hawaii (1)
Idaho (64)
Illinois (682)
India (29)
Indiana (369)
Iowa (18)
Japan (237)
Kansas (113)
Kentucky (30)
Louisiana (14)
Maine (73)
Maryland (1073)
Massachusetts (5779)
Michigan (252)
Minnesota (473)
Mississippi (3)
Missouri (101)
Montana (31)
Nebraska (26)
Nevada (82)
New Hampshire (72)
New Jersey (2133)
New Mexico (30)
New York (2147)
North Carolina (1166)
North Dakota (10)
Northern California (3338)
Ohio (246)
Oklahoma (17)
Oregon (38)
Pennsylvania (1641)
Puerto Rico (18)
Rhode Island (37)
South America (1319)
South Carolina (34)
South Dakota (1)
Southern California (2856)
Tennessee (129)
Texas (1153)
United States (28570)
Utah (223)
Virginia (198)
Washington D.C. (74)
Washington State (659)
West Virginia (4)
Wisconsin (70)
763,576 Results for "social and scientific systems inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Genetown
Thermo Fisher Scientific Releases 2023 Corporate Social Responsibility Report
Thermo Fisher Scientific Inc., the world leader in serving science, released its 2023 Corporate Social Responsibility report, which provides an overview of the company, its CSR priorities and the progress enabled by its more than 120,000 colleagues.
May 28, 2024
·
3 min read
Press Releases
Hemostemix’s Social Media Awareness of “Your Fountain of Youth"(TM) Regenerative Medicine Treatments Is Gaining Traction
Hemostemix is revolutionizing how individuals think about their own regenerative medicine treatments. With social media, the company is educating individuals about treatments and advancements.
January 2, 2025
·
6 min read
Press Releases
Ontada Unveils Comprehensive Data on Social Determinants of Health and Outcomes of Early-Onset Colorectal Cancer at ASCO
May 30, 2025
·
6 min read
Press Releases
Perimeter Partners with Intermountain Health to Study the Potential Clinical, Social and Economic Benefits of Using OCT and AI to Reduce Cancer Reoperations
May 23, 2025
·
6 min read
Pharm Country
Amneal Releases 2023 Environmental, Social and Governance Report
Amneal Pharmaceuticals, Inc. announced the release of its fourth Environmental, Social and Governance Report.
June 28, 2024
·
9 min read
Editorial
Biomedical Innovation in Jeopardy as Kennedy Distorts, Denies Scientific Truths
As the Trump administration—including HHS Secretary Robert F. Kennedy Jr.—plays fast and loose with scientific studies and facts, there may be a more sinister force at play: censorship.
May 2, 2025
·
6 min read
·
Heather McKenzie
Press Releases
Apotex publishes 2024 Sustainability Report, highlighting progress and achievements in environmentally sustainable manufacturing, responsible business practices, and social impact
May 21, 2025
·
2 min read
Press Releases
Boston Scientific receives FDA approval for expanded labeling of FARAPULSE™ Pulsed Field Ablation System
July 8, 2025
·
6 min read
Press Releases
Vistagen on Track to Deliver Topline Data From Fasedienol PALISADE-3 Phase 3 Trial for Acute Treatment of Social Anxiety Disorder in the Fourth Quarter of This Year
June 2, 2025
·
8 min read
Press Releases
Rarecells, Inc. Appoints Dr. Rita Shaknovich to Scientific Advisory Board
June 18, 2025
·
2 min read
1 of 76,358
Next
